Bupivacaine Hydrochloride Injection, Solution
Product Images NDC 71872-7217

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bupivacaine Hydrochloride (NDC 71872-7217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7217-1.pdp (71872 7217 1)

Label of Bupivacaine Hydrochloride Injection USP 0.25% (2.5 mg/mL) solution in a 50 mL multiple-use fliptop vial. The label states it contains 125 mg per 50 mL and is intended for infiltration and nerve block, not for caudal, epidural, or spinal anesthesia. It lists inactive ingredients, storage instructions, and manufacturing details, showing Medical Purchasing Solutions, LLC as labeler and Hospira, Inc. as distributor, with the product made in Switzerland.*

FDA Label Image

Hospira Logo (Bupivacaine 01)

FDA Label Image

Structural Formula Bupivacaine Hydrochloride (Bupivacaine 02)

Chemical structure diagram depicting Bupivacaine Hydrochloride, showing its molecular components including a piperidine ring, alkyl side chains, an amide bond, a substituted aromatic ring with methyl groups, and associated hydrochloride and water molecules.*

FDA Label Image

Structural Formula Epinephrine (Bupivacaine 03)

Chemical structure of Bupivacaine Hydrochloride showing the arrangement of hydroxyl groups, aromatic ring, and amine side chain as part of the molecule.*

FDA Label Image

Hospira Logo (Bupivacaine 04)

FDA Label Image

Principal Display Panel (125 mg/50 mL Vial Label)

Label for Bupivacaine Hydrochloride Injection, USP 0.25% (2.5 mg/mL) in a 50 mL multiple-dose fliptop vial. The solution strength is 125 mg per 50 mL. Indicated for infiltration and nerve block, with a warning against use for caudal, epidural, or spinal anesthesia. The label includes ingredients, storage instructions, distributor Hospira, Inc., and NDC 0409-1160-18.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.